Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Kohler

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Archives of Neurology|December 1, 1987
Guillain-Barré syndrome following Campylobacter jejuni enteritisP C Kohler, D Goldblatt
Cancer Investigation|January 1, 1986
Ectopic hormone syndromesP C Kohler, D L Trump
Cancer Surveys|January 1, 1989
The role of interleukin-2 in cancer therapyP C Kohler, P M Sondel
Oncology (Williston Park, N.Y.)|August 1, 1987
Status and potential of interleukin-2 for the treatment of neoplastic diseaseP M Sondel, J A Hank, P C Kohler
Archives of Internal Medicine|November 1, 1982
Intermittent Cushing's syndrome with an empty sella turcicaD J Smith, P C Kohler, R Helminiak, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Clinical adoptive chemoimmunotherapy with allogeneic alloactivated HLA-haploidentical lymphocytes: controlled induction of graft-versus-host-reactionsP C Kohler, J A Hank, D Z Minkoff, et al.
Progress in Clinical and Biological Research|January 1, 1989
"Lymphokine activated killing" as treatment for human cancer: clinical extrapolations from laboratory studies with interleukin-2 expanded leukocytesP M Sondel, J A Hank, P C Kohler, et al.
The New England Journal of Medicine|May 25, 1989
Tumor-infiltrating lymphocytes and interleukin-2 in melanomasP M Sondel, J A Sosman, J A Hank, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1991
Phase I study of toremifene in patients with advanced cancerJ T Hamm, D C Tormey, P C Kohler, et al.
Progress in Clinical and Biological Research|January 1, 1987
Phase 1 clinical evaluation of recombinant interleukin-2P C Kohler, J A Hank, K H Moore, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Archives of Neurology|December 1, 1987
Guillain-Barré syndrome following Campylobacter jejuni enteritisP C Kohler, D Goldblatt
Cancer Investigation|January 1, 1986
Ectopic hormone syndromesP C Kohler, D L Trump
Cancer Surveys|January 1, 1989
The role of interleukin-2 in cancer therapyP C Kohler, P M Sondel
Oncology (Williston Park, N.Y.)|August 1, 1987
Status and potential of interleukin-2 for the treatment of neoplastic diseaseP M Sondel, J A Hank, P C Kohler
Archives of Internal Medicine|November 1, 1982
Intermittent Cushing's syndrome with an empty sella turcicaD J Smith, P C Kohler, R Helminiak, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Clinical adoptive chemoimmunotherapy with allogeneic alloactivated HLA-haploidentical lymphocytes: controlled induction of graft-versus-host-reactionsP C Kohler, J A Hank, D Z Minkoff, et al.
Progress in Clinical and Biological Research|January 1, 1989
"Lymphokine activated killing" as treatment for human cancer: clinical extrapolations from laboratory studies with interleukin-2 expanded leukocytesP M Sondel, J A Hank, P C Kohler, et al.
The New England Journal of Medicine|May 25, 1989
Tumor-infiltrating lymphocytes and interleukin-2 in melanomasP M Sondel, J A Sosman, J A Hank, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1991
Phase I study of toremifene in patients with advanced cancerJ T Hamm, D C Tormey, P C Kohler, et al.
Progress in Clinical and Biological Research|January 1, 1987
Phase 1 clinical evaluation of recombinant interleukin-2P C Kohler, J A Hank, K H Moore, et al.
Pageof 4